Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy
Phase of Trial: Phase IV
Latest Information Update: 17 Jul 2019
At a glance
- Drugs Dexrazoxane (Primary) ; Doxorubicin
- Indications Chemotherapy-induced damage
- Focus Therapeutic Use
- Acronyms HEART
- 07 Aug 2018 Planned primary completion date changed from 1 Jan 2019 to 30 Mar 2022.
- 05 Apr 2016 Trial protocol (Treatment arms, study design, endpoints) amended as reported by ClinicalTrials.gov record.
- 22 Feb 2013 New trial record